Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ambu A/S Unsponsored ADR (AMBBY : OTC)

• Company Description    Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark. Number of Employees: 5,196

• Price / Volume Information    Yesterday's Closing Price: $15.45 Daily Weekly Monthly 20 Day Moving Average: 112 shares Shares Outstanding: 234.97 (millions) Market Capitalization: $3,630.35 (millions) Beta: 0.90 52 Week High: $22.65 52 Week Low: $13.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.25% -2.30% 12 Week -10.28% -23.37% Year To Date 18.66% 11.15%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BALTORPBAKKEN 13 - BALLERUP,G7 DK-2750 DNK ph: 45-7225-2910 fax: - anhj@ambu.com http://www.ambu.com

• General Corporate Information    Officers Britt Meelby Jensen - Chief Executive Officer Jorgen Jensen - Chairman Steven Block - President Graziela Malucelli - Chief Operations Officer Henrik Bender - Chief Financial Officer Peer Information Ambu A/S Unsponsored ADR (MGLHQ) Ambu A/S Unsponsored ADR (AMBBY) Ambu A/S Unsponsored ADR (HMA.) Ambu A/S Unsponsored ADR (CPMIQ) Ambu A/S Unsponsored ADR (FPAMQ) Ambu A/S Unsponsored ADR (PSYS2) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-HOSPITALS Sector: Medical CUSIP: 02337W109 SIC: 6770 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/25 Next Expected EPS Date: - Share - Related Items Shares Outstanding: 234.97 Most Recent Split Date: (:1) Beta: 0.90 Market Capitalization: $3,630.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.19% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.03 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.15 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.12 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 81.32 PEG Ratio: - Price Ratios Price/Book: 4.35 Price/Cash Flow: 26.82 Price / Sales: 4.33 EPS Growth vs. Year Ago Period: 25.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 10.08% vs. Previous Quarter: 1.46% ROE 06/30/25 - - 03/31/25 - 6.31 12/31/24 - 5.67 ROA 06/30/25 - - 03/31/25 - 4.97 12/31/24 - 4.46 Current Ratio 06/30/25 - - 03/31/25 - 2.88 12/31/24 - 2.60 Quick Ratio 06/30/25 - - 03/31/25 - 1.67 12/31/24 - 1.47 Operating Margin 06/30/25 - - 03/31/25 - 6.21 12/31/24 - 5.69 Net Margin 06/30/25 - - 03/31/25 - 6.21 12/31/24 - 5.69 Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 3.55 12/31/24 - 3.52 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.08 12/31/24 - 0.08 Debt-to-Capital 06/30/25 - - 03/31/25 - 7.48 12/31/24 - 7.78

Powered by Zacks Investment Research ©